David Lowrance
Financieel Directeur/CFO bij SAVARA INC.
Vermogen: 366 480 $ op 30-04-2024
Actieve functies van David Lowrance
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SAVARA INC. | Hoofd Administratief Officier | 13-12-2022 | - |
Financieel Directeur/CFO | 27-04-2017 | - | |
Bedrijfssecretaris | 01-07-2017 | 13-12-2022 | |
Washington Biotechnology & Biomedical Association | Directeur/Bestuurslid | 01-07-2014 | - |
Loopbaan van David Lowrance
Eerdere bekende functies van David Lowrance
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Financieel Directeur/CFO | 01-09-2014 | 01-10-2016 |
Treasurer | 01-09-2014 | 01-10-2016 | |
ACUCELA INC | Financieel Directeur/CFO | 01-04-2011 | 19-09-2014 |
Bedrijfssecretaris | 01-04-2011 | 19-09-2014 | |
CUMBERLAND PHARMACEUTICALS INC. | Financieel Directeur/CFO | 01-03-2003 | 04-04-2011 |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Financieel Directeur/CFO | 01-11-2016 | - |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Financieel Directeur/CFO | - | - |
BORGWARNER INC. | Financieel Directeur/CFO | - | - |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-1994 | - |
Opleiding van David Lowrance
University of Georgia | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Duitsland | 2 |
Japan | 2 |
Operationeel
Director of Finance/CFO | 7 |
Corporate Secretary | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
BORGWARNER INC. | Producer Manufacturing |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
SAVARA INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Health Technology |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
- Beurs
- Insiders
- David Lowrance
- Ervaring